Clinical Supply Logistic Articles
-
Three Months Too Late: How Late Decisions Create Clinical Supply Challenges
10/20/2026
Many clinical supply challenges arise not from gaps in protocol information, but from operational implications recognized too late to influence decisions, as experts explain here.
-
The Hidden Work Between Protocol And Execution: Translating Requirements Into Supply Strategy
10/20/2026
Understanding protocol requirements is only part of the execution challenge. Here, experts explain how intent becomes operational plans, system configurations, and supply strategy.
-
Clinical Trial Supply In The EU And U.K.: A Regulatory Guide
10/20/2026
EU and U.K. clinical trial rules are evolving separately. Here’s what sponsors need to consider across QP release, labeling, importation, and supply continuity.
-
Can Standardizing Protocols Improve Clinical Supply Execution?
10/14/2026
M11 may standardize protocol information, but as experts explain here, successful clinical supply execution depends on much more than what’s in the protocol.
-
Direct-To-Patient Trials Are Changing The Clinical Supply Chain
10/14/2026
Direct-to-patient trials are reshaping clinical supply, forcing teams to rethink inventory, delivery, forecasting, and contingency planning around the patient.
-
The Bullwhip Effect Hits Clinical Supply Chains
10/12/2026
A small enrollment change can become a major supply swing. See how the bullwhip effect distorts clinical demand signals and what teams can do to dampen it.
-
Rare Disease Trials: Execution Risks No One Warns You About
10/6/2026
Rare disease trials demand a different approach to site selection, forecasting, supply, and patient logistics because every patient counts. Explore what can go wrong.
-
The Patient Is In The Room. Who Is Dispensing The IP?
10/1/2026
Receiving IP is only the beginning. Explore how the first patient visit can expose gaps in dispensing, delegation, IRT, documentation, and site readiness.
-
When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
10/1/2026
Radiopharmaceuticals turn time into a supply-chain constraint. Short half-lives, patient scheduling, scarce radionuclides and regulatory differences reshape trial logistics.
-
One IP Receipt Problem Is An Exception. Four Is A Process.
9/30/2026
Repeated IP receipt problems can reveal a site readiness gap. Learn how recurring CRA intervention can expose fragile processes that need to work without rescue.